Reply to ‘The shift of therapeutic strategy for prolactinomas: surgery as the first-line option’

Nature Reviews Endocrinology, Published online: 22 January 2024; doi:10.1038/s41574-024-00954-4Reply to ‘The shift of therapeutic strategy for prolactinomas: surgery as the first-line option’

https://www.nature.com/articles/s41574-024-00954-4

Source: Nature Reviews Endocrinology - January 22, 2024 Category: Endocrinology Authors: Stephan Petersenn Maria Fleseriu Shlomo Melmed Source Type: research

More News: Endocrinology